CN Patent

CN106957314B — 用作raf激酶抑制剂的嘧啶衍生物

Assigned to Dot Therapy 1 Co · Expires 2019-12-31 · 6y expired

What this patent protects

本发明提供用作Raf蛋白激酶抑制剂的化合物。本发明也提供它们的组合物和治疗Raf‑介导的疾病的方法。

USPTO Abstract

本发明提供用作Raf蛋白激酶抑制剂的化合物。本发明也提供它们的组合物和治疗Raf‑介导的疾病的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN106957314B
Jurisdiction
CN
Classification
—
Expires
2019-12-31
Drug substance claim
No
Drug product claim
No
Assignee
Dot Therapy 1 Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.